• English
  • Français
Bladder Cancer CanadaBladder Cancer CanadaBladder Cancer CanadaBladder Cancer Canada
  • Bladder Cancer
    • See Red?
    • What is Bladder Cancer?
    • Statistics and Risk Factors
    • Symptoms and Diagnosis
    • Staging and Grading
    • Types of Bladder Cancer
      • Non-Muscle Invasive Bladder Cancer
      • Muscle Invasive Bladder Cancer
      • Metastatic Bladder Cancer
      • Upper Tract Urothelial Carcinoma
    • Treatment Options
      • TURBT
      • BCG
      • Chemotherapy and Radiation
      • Bladder Removal Surgery
      • Immunotherapy
      • Bladder Preservation Options
      • Palliative Care
      • Clinical Trials
      • Advanced Bladder Cancer Treatment
    • Research and Studies
  • Patients
    • Get Support
      • Support Groups
      • One2One Peer Support
      • Online Discussion Forum
      • Contact Us by Phone or Email
    • Navigating Your Diagnosis
      • Newly Diagnosed?
      • Coping With Emotions
      • Health and Wellness Resources
      • Clinical Trials
    • Educational Resources
      • Guidebooks
      • Webinars and Videos
      • Podcast
      • Newsletter
      • Glossary
    • Upcoming Events
    • News and Stories
    • Links and Other Resources
  • Get Involved
    • Donate
    • Fundraise
    • Volunteer
    • Share Your Story
    • Patient Study Recruitment
    • Patient Self-Advocacy
    • Bladder Cancer Awareness Month
    • Your Impact
  • Health Care Practitioners
    • Doctor Resources
    • BCC Research Grant Applications
    • BCC Research Grant Recipients
    • CBCIS
    • CBCRN
    • Medical Advisory Board
  • About Us
    • Who We Are
    • Board of Directors
    • Staff
    • Medical Advisory Board
    • Sponsors and Partners
    • Financial Statements and Annual Reports
    • Newsletter
    • Contact Us
  • Walk With Us
  • Donate
NextPrevious

BCC Medical Research Board members awarded joint grant with CUASF

By Bladder Cancer Canada | Latest news and stories | 10 July, 2017 | 0

This year, Bladder Cancer Canada (BCC) is co-funding a $50,000 grant for bladder cancer research in partnership with the Canadian Urological Association Scholarship Foundation (CUASF).  The CUASF is a scholarship fund that was set up by the Canadian Urological Association and its Members, and has a long and successful history.

Both recipients of this year’s grant are members of BCC’s Medical Research Board, Dr. Peter Black and Dr. Girish Kulkarni. Below are descriptions of their research:

 

Phenotypical analysis of the immune system in patients with MIBC

Peter Black, MD, FACS, FRCSC  

The immune system has the potential to kill tumour cells, however most cancers, including bladder cancer, develop ways to evade the immune system. Although there have been recent successes with treatments aimed at activating anti-cancer immune responses, most patients do not respond to therapy, which highlights the need to better understand how tumours  suppress anti-cancer immune responses. This proposal aims to characterize the state of the immune system in patients with muscle-invasive bladder cancer, in order to better understand how bladder cancer suppresses the immune system, and to define new targets for therapies that could re-activate immune mediated killing of tumour cells.

 

A comparison of patient outcomes with a repeat resection versus no repeat resection in high-grade T1 bladder cancer

Girish Kulkarni, MD, PHD, FRCSC

Photo credit: John Packman

The majority of bladder cancer is diagnosed when it is confined to the bladder and not invading the bladder wall. Certain types of bladder cancer (T1) have higher likelihood for potentially invading the bladder wall which necessitates removal of the bladder. These tumours are diagnosed by scraping the tumour off of the bladder wall. The purpose of this proposal is to assess whether a repeat scraping of the bladder wall improves cancer staging accuracy (ie. upstaging to muscle invasion or truly T1 disease, not invading the muscle) when patients are initial diagnosed with T1 bladder cancer.

No tags.

Related Post

  • Volunteer’s personal approach leads to deeper commitment from corporate supporter

    By Bladder Cancer Canada | 0 comment

    By: Tom Eremondi Read time: 3.5 minutes Admittedly old school, Gerry Ross’ approach to dealing with a local walk sponsor nurtured and enhanced the relationship to a surprising level. This story, however, dates back aboutRead more

  • “The risk of recurrence of my cancer is high, so I need to take care of myself.”

    By Bladder Cancer Canada | 0 comment

    Read time: 2 minutes We were so pleased to see one of our new Peer Support Volunteers, Gervais  Fournier, featured in this New Normal, Same Cancer news story, seen last month in the Le JournalRead more

  • This May, we’re making bladder cancer impossible to ignore! 

    By Bladder Cancer Canada | Comments are Closed

    Subscribe today! Our May newsletter is filled with lots of initiatives to create awareness for bladder cancer including blogs, podcasts, helpful facts, webinars and more. Bladder cancer is the 5th most common cancer in Canada andRead more

  • Bladder cancer & COVID-19 FAQ

    By Bladder Cancer Canada | Comments are Closed

    Uncertain times are upon us, around the world, as we globally respond to the coronavirus (COVID-19) that is affecting us all on some level. Many members of our bladder cancer community are directing questions our way aboutRead more

  • Protecting Yourself During the Coronavirus Outbreak

    By Bladder Cancer Canada | Comments are Closed

    (The following content is sourced from various sites advising on the coronavirus. For more information, please see the end of this article for additional resources. Photo Credit: CDC) As news of the coronavirus (COVID-19) continues toRead more

  • Health Canada Approves BALVERSA

    By Bladder Cancer Canada | Comments are Closed

    In a recent press release, Janssen Pharmaceutical Companies of Johnson & Johnson have announced that they have received approval from Health Canada for BALVERSA™ (erdafitinib), the first FGFR Kinase inhibitor for the treatment of patientsRead more

  • Patient Story: Ann

    By Bladder Cancer Canada | Comments are Closed

    I was diagnosed with bladder cancer after a significant amount of blood appeared in my urine.

  • Announcing the Launch of Our New Hematuria Brochure: A Vital Resource for Early Bladder Cancer Detection 

    By Bladder Cancer Canada | Comments are Closed

    We have developed this easy-to-understand resource aimed at increasing awareness of hematuria.

  • Our First Annual Research Report Is Live! 

    By Bladder Cancer Canada | Comments are Closed

    Our first Annual Research Report brings you exciting updates from the world of bladder cancer research.

  • Tax Season is Upon Us! 

    By Bladder Cancer Canada | Comments are Closed

    Spring has sprung and so has tax season! Don’t miss out on valuable credits or deductions! 

  • Happy National Volunteer Week 2025!

    By Bladder Cancer Canada | Comments are Closed

    National Volunteer Week is celebrated annually to honour all the volunteers who make a powerful impact.

NextPrevious

Recent Blog Posts

  • Patient Story: Ann
  • Announcing the Launch of Our New Hematuria Brochure: A Vital Resource for Early Bladder Cancer Detection 
  • Our First Annual Research Report Is Live! 
  • Economic Impacts of a Cancer Diagnosis on Canadians
  • Tax Season is Upon Us! 

Upcoming Events

  • Outreach Events
  • In-person Education Events
  • Support Groups
  • Webinars

Blog Categories

  • Blog
  • Honouring our volunteers
  • Latest news and stories
  • Patient Stories
  • Upcoming meeting and events
  • Volunteers
  • Webinar

Bladder Cancer Canada

4936 Yonge Street, Suite 1000, Toronto, ON M2N 6S3
Phone: 1-866-674-8889
Email & Media Contact: info@bladdercancercanada.org

Privacy Policy | Donor Bill of Rights

Charitable Reg No. 83612 6060 RR0001

© Bladder Cancer Canada.

SUBSCRIBE TO OUR NEWSLETTER
SEND US A MESSAGE
  • Bladder Cancer
    • See Red?
    • What is Bladder Cancer?
    • Statistics and Risk Factors
    • Symptoms and Diagnosis
    • Staging and Grading
    • Types of Bladder Cancer
      • Non-Muscle Invasive Bladder Cancer
      • Muscle Invasive Bladder Cancer
      • Metastatic Bladder Cancer
      • Upper Tract Urothelial Carcinoma
    • Treatment Options
      • TURBT
      • BCG
      • Chemotherapy and Radiation
      • Bladder Removal Surgery
      • Immunotherapy
      • Bladder Preservation Options
      • Palliative Care
      • Clinical Trials
      • Advanced Bladder Cancer Treatment
    • Research and Studies
  • Patients
    • Get Support
      • Support Groups
      • One2One Peer Support
      • Online Discussion Forum
      • Contact Us by Phone or Email
    • Navigating Your Diagnosis
      • Newly Diagnosed?
      • Coping With Emotions
      • Health and Wellness Resources
      • Clinical Trials
    • Educational Resources
      • Guidebooks
      • Webinars and Videos
      • Podcast
      • Newsletter
      • Glossary
    • Upcoming Events
    • News and Stories
    • Links and Other Resources
  • Get Involved
    • Donate
    • Fundraise
    • Volunteer
    • Share Your Story
    • Patient Study Recruitment
    • Patient Self-Advocacy
    • Bladder Cancer Awareness Month
    • Your Impact
  • Health Care Practitioners
    • Doctor Resources
    • BCC Research Grant Applications
    • BCC Research Grant Recipients
    • CBCIS
    • CBCRN
    • Medical Advisory Board
  • About Us
    • Who We Are
    • Board of Directors
    • Staff
    • Medical Advisory Board
    • Sponsors and Partners
    • Financial Statements and Annual Reports
    • Newsletter
    • Contact Us
  • Walk With Us
  • Donate
Bladder Cancer Canada